【正文】 Norvanycin............................. 33 Lipid Regulating Drugs and Antiartherosclerosis Drugs Report ............. 33 Research Report on Chinese diabetes Market .............................................. 35 Market Research Report On Osteoporosis Drugs........................................... 37 ACEI Antihypertensive Market Report .......................................................... 38 Myocardial Preservation Drugs and Nutritional Drugs Report .................. 39 Market Research Report on Antianxiety Drugs ............................................ 40 Market Research Report on Anticancer Drug Docetaxel .............................. 41 Research Report on Chinese Coenzyme A Market........................................... 42 Amino Acids Infusion Report ........................................................................ 42 Research Report on Chinese SedativeHypnotics Market............................. 43 Cerebral Function Improving Drugs Report.................................................. 44 Opportunities in Chinese Anticancer Drugs Market.................................... 45 Plantoriginated and CTM Anticancer Drugs Report.................................... 46 Anticancer Drugs Market Report ................................................................... 47 Drugs for Hepatopathy Report....................................................................... 49 Venlafaxine Market Report ............................................................................ 50 Stomach Drugs Market Report ........................................................................ 51 Antiarrhythic Drugs Report .......................................................................... 52 Antidepressant Drugs Report ........................................................................ 53 Vinorelbine Anticancer Drug ........................................................................ 54 Carbapenem antimicrobial drugs Report ....................................................... 55 Market Research Report on Rhinitis Drugs.................................................. 58 Cardiovascular drugs report ........................................................................ 60 健康網(wǎng)專(zhuān)題研究報(bào)告介紹 地址 ：北京市西城區(qū)阜外大街 2 號(hào)萬(wàn)通新世界廣場(chǎng) A 座 20 層 20xx 室（ 100037） 電話： 01068012929 傳真： 01068052505 9 Infusion solution report.............................................................................. 63 Gadopentetate Dimeglumine MRI Contrast Medium Report............................. 64 Antiallergic drugs market report................................................................ 64 Sodium Hyaluronate Report ............................................................................ 68 Hemostatic Drugs and Hemocoagulase Report ................................................ 69 Thrombolytic Drug Market Report ................................................................. 70 External dermatological drugs report......................................................... 71 Chinese Heparin derivatives market ............................................................ 73 Chinese insulin market report(20xx edition) ............................................ 74 Chinese Acarbose market report ................................................................... 75 Clopidogrel Chinese market report .............................................................. 76 健康網(wǎng)專(zhuān)題研究報(bào)告介紹 地址：北京市西城區(qū)阜外大街 2 號(hào)萬(wàn)通新世界廣場(chǎng) A 座 20 層 20xx 室（ 100037） 電話： 01068012929 傳真： 01068052505 1 產(chǎn)品報(bào)告 抗感染類(lèi) 中國(guó)抗生素類(lèi)藥物市場(chǎng)結(jié)構(gòu)報(bào)告（ 20xx 版） 【報(bào)告名稱】：中國(guó)抗生素類(lèi)藥物市場(chǎng)結(jié)構(gòu)報(bào)告（ 20xx 版） 【報(bào)告類(lèi)別】：年度產(chǎn)品報(bào)告 【完成日期】： 20xx 年 5 月 【報(bào)告格式】：電子版、報(bào)告全文紙版 (彩色 ) 【交付方式】： EMAIL 電子版或 EMS 印刷版 【價(jià) 格】：￥ 6800 目 錄 一、整體市場(chǎng)結(jié)構(gòu) .............................................1 20xx 年國(guó)內(nèi)整體醫(yī)藥市場(chǎng)份額 ................................1 20xx 年國(guó)內(nèi)化學(xué)藥品市場(chǎng)份額 ................................2 20xx 年抗感染藥物市場(chǎng)份額 ..................................3 20xx 年抗生素市場(chǎng)分類(lèi)排序 ..................................6 20xx 年中國(guó)抗生素排名前 100 位產(chǎn)品及份額 .....................6 20xx～ 20xx 年抗細(xì)菌藥物增長(zhǎng)率最快的類(lèi)別 ....................10 20xx～ 20xx 年抗生素增長(zhǎng)率最快的藥品及其排名 ................11 二、 20xx 年抗生素產(chǎn)品銷(xiāo)售份額與排序 ...........................15 頭孢菌素類(lèi) ................................................15 喹諾酮類(lèi) ..................................................16 青霉素類(lèi) ..................................................17 大環(huán)內(nèi)酯類(lèi) ................................................17 碳青霉烯類(lèi) ................................................18 林可胺類(lèi) ..................................................18 硝咪唑類(lèi) ..................................................19 氨基糖苷類(lèi) ................................................19 健康網(wǎng)專(zhuān)題研究報(bào)告介紹 地址：北京市西城區(qū)阜外大街 2 號(hào)萬(wàn)通新世界廣場(chǎng) A 座 20 層 20xx 室（ 100037） 電話： 01068012929 傳真： 01068052505 2 糖肽類(lèi)抗生素 ..............................................19 植物藥抗感染制劑 .........................................19 1四環(huán)素類(lèi) .................................................20 1氯霉素類(lèi) .................................................20 1磺胺類(lèi) ...................................................20 1青霉烯類(lèi) .................................................21 1其他抗細(xì)菌類(lèi) .............................................21 1抗病毒藥類(lèi) ...............................................22 1全身用抗真菌藥 ...........................................23 1免疫血清和免疫球蛋白 .....................................23 1抗分枝桿菌藥 .............................................23 疫 苗 ....................................................24 三、 20xx 年各類(lèi)抗生素主要產(chǎn)品企業(yè)銷(xiāo)售份額與排序 ...............25 1 頭孢菌素類(lèi) .................................................25 2 喹諾酮類(lèi) ...................................................35 3 青霉素類(lèi) ...................................................40 4 大環(huán)內(nèi)酯類(lèi) .................................................46 5 碳青霉烯類(lèi) .................................................49